{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:09Z","timestamp":1791308829216,"version":"4.3.1"},"reference-count":50,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":3144,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,2,1]]},"abstract":"<jats:p>Two-thirds of adults in the U.S. are overweight or obese, and another 26 million have type 2 diabetes (T2D). Patients with diabetes and\/or the metabolic syndrome have a significantly increased risk of heart attack and stroke compared with people with normal insulin sensitivity. Decreased insulin sensitivity in cardiovascular tissues as well as in traditional targets of insulin metabolic signaling, such as skeletal muscle, is an underlying abnormality in obesity, hypertension, and T2D. In the vasculature, insulin signaling plays a critical role in normal vascular function via endothelial cell nitric oxide production and modulation of Ca2+ handling and sensitivity in vascular smooth muscle cells. Available evidence suggests that impaired vascular insulin sensitivity may be an early, perhaps principal, defect of vascular function and contributor to the pathogenesis of vascular disease in persons with obesity, hypertension, and T2D. In the overweight and obese individual, as well as in persons with hypertension, systemic and vascular insulin resistance often occur in concert with elevations in plasma aldosterone. Indeed, basic and clinical studies have demonstrated that elevated plasma aldosterone levels predict the development of insulin resistance and that aldosterone directly interferes with insulin signaling in vascular tissues. Furthermore, elevated plasma aldosterone levels are associated with increased heart attack and stroke risk. Conversely, renin\u2013angiotensin\u2013aldosterone system and mineralocorticoid receptor (MR) antagonism reduces cardiovascular risk in these patient populations. Recent and accumulating evidence in this area has implicated excessive Ser phosphorylation and proteosomal degradation of the docking protein, insulin receptor substrate, and enhanced signaling through hybrid insulin\/IGF-1 receptor as important mechanisms underlying aldosterone-mediated interruption of downstream vascular insulin signaling. Prevention or restoration of these changes via blockade of aldosterone action in the vascular wall with MR antagonists (i.e., spironolactone, eplerenone) may therefore account for the clinical benefit of these compounds in obese and diabetic patients with cardiovascular disease. This review will highlight recent evidence supporting the hypothesis that aldosterone and MR signaling represent an ideal candidate pathway linking early promoters of diabetes, especially overnutrition and obesity, to vascular insulin resistance, dysfunction, and disease.<\/jats:p>","DOI":"10.2337\/db12-0905","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T23:59:41Z","timestamp":1359071981000},"page":"313-319","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":143,"title":["Mineralocorticoid Receptor\u2013Mediated Vascular Insulin Resistance"],"prefix":"10.2337","volume":"62","author":[{"given":"Shawn B.","family":"Bender","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Missouri School of Medicine, Columbia, Missouri"},{"name":"Diabetes and Cardiovascular Center, Harry S. Truman VA Medical Center, Columbia, Missouri; the"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"McGraw","sequence":"additional","affiliation":[{"name":"Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris Z.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Sowers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Missouri School of Medicine, Columbia, Missouri"},{"name":"Diabetes and Cardiovascular Center, Harry S. Truman VA Medical Center, Columbia, Missouri; the"},{"name":"Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,1,17]]},"reference":[{"key":"2022031210112042600_B1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2022031210112042600_B2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/eurheartj\/ehr176","article-title":"Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure","volume":"33","author":"Ivanes","year":"2012","journal-title":"Eur Heart J"},{"key":"2022031210112042600_B3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","article-title":"Mineralocorticoid receptors in vascular function and disease","volume":"350","author":"McCurley","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2022031210112042600_B4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","author":"Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","journal-title":"Lancet"},{"key":"2022031210112042600_B5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2022031210112042600_B6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2022031210112042600_B7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1463-1326.2007.00730.x","article-title":"Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS","volume":"10","author":"O\u2019Keefe","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"2022031210112042600_B8","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1161\/CIRCULATIONAHA.108.772665","article-title":"Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials","volume":"118","author":"Vergeer","year":"2008","journal-title":"Circulation"},{"key":"2022031210112042600_B9","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1161\/CIRCULATIONAHA.108.790733","article-title":"Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation)","volume":"118","author":"Nicholls","year":"2008","journal-title":"Circulation"},{"key":"2022031210112042600_B10","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1210\/jc.2007-0393","article-title":"Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus","volume":"92","author":"Joffe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031210112042600_B11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ Res"},{"key":"2022031210112042600_B12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ Res"},{"key":"2022031210112042600_B13","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/ATVBAHA.111.229070","article-title":"Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways","volume":"31","author":"Newfell","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210112042600_B14","article-title":"Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors","author":"McCurley","journal-title":"Nat Med"},{"key":"2022031210112042600_B15","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"2022031210112042600_B16","doi-asserted-by":"crossref","first-page":"H1597","DOI":"10.1152\/ajpheart.00026.2004","article-title":"Insulin resistance and hypertension","volume":"286","author":"Sowers","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031210112042600_B17","doi-asserted-by":"crossref","first-page":"H2281","DOI":"10.1152\/ajpheart.00566.2007","article-title":"Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and alpha1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes","volume":"293","author":"Bender","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031210112042600_B18","doi-asserted-by":"crossref","first-page":"H1434","DOI":"10.1152\/ajpheart.01093.2010","article-title":"Differential vulnerability of skeletal muscle feed arteries to dysfunction in insulin resistance: impact of fiber type and daily activity","volume":"300","author":"Bender","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031210112042600_B19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cmet.2011.01.018","article-title":"Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle","volume":"13","author":"Kubota","year":"2011","journal-title":"Cell Metab"},{"key":"2022031210112042600_B20","doi-asserted-by":"crossref","first-page":"E1134","DOI":"10.1152\/ajpendo.00516.2006","article-title":"Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa\/fa) rats","volume":"293","author":"Eringa","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031210112042600_B21","doi-asserted-by":"crossref","first-page":"H1780","DOI":"10.1152\/ajpheart.01297.2005","article-title":"Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats","volume":"291","author":"Oltman","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031210112042600_B22","doi-asserted-by":"crossref","first-page":"H854","DOI":"10.1152\/ajpheart.00715.2004","article-title":"Impaired insulin-induced vasodilation in small coronary arteries of Zucker obese rats is mediated by reactive oxygen species","volume":"288","author":"Katakam","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031210112042600_B23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejphar.2009.11.038","article-title":"Vascular insulin resistance in prehypertensive rats: role of PI3-kinase\/Akt\/eNOS signaling","volume":"628","author":"Li","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"2022031210112042600_B24","doi-asserted-by":"crossref","first-page":"H853","DOI":"10.1152\/ajpheart.00138.2007","article-title":"Dissociation between metabolic and vascular insulin resistance in aging","volume":"293","author":"Schulman","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031210112042600_B25","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1210\/jc.2003-032161","article-title":"Impaired endothelial function in never-treated hypertensive subjects carrying the Arg972 polymorphism in the insulin receptor substrate-1 gene","volume":"89","author":"Perticone","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031210112042600_B26","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2337\/db07-1111","article-title":"Effect of endothelium-specific insulin resistance on endothelial function in vivo","volume":"57","author":"Duncan","year":"2008","journal-title":"Diabetes"},{"key":"2022031210112042600_B27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11906-011-0182-2","article-title":"The role of aldosterone in the metabolic syndrome","volume":"13","author":"Briet","year":"2011","journal-title":"Curr Hypertens Rep"},{"key":"2022031210112042600_B28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0895-7061(99)00016-3","article-title":"Moderate dietary salt restriction increases vascular and systemic insulin resistance","volume":"12","author":"Feldman","year":"1999","journal-title":"Am J Hypertens"},{"key":"2022031210112042600_B29","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1210\/jc.2009-2521","article-title":"Aldosterone production and insulin resistance in healthy adults","volume":"95","author":"Garg","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031210112042600_B30","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1096\/fj.07-9412com","article-title":"A novel adipokine CTRP1 stimulates aldosterone production","volume":"22","author":"Jeon","year":"2008","journal-title":"FASEB J"},{"key":"2022031210112042600_B31","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/HYPERTENSIONAHA.107.093955","article-title":"Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells","volume":"50","author":"Hitomi","year":"2007","journal-title":"Hypertension"},{"key":"2022031210112042600_B32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/ATVBAHA.111.240697","article-title":"Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor","volume":"32","author":"Sherajee","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210112042600_B33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mce.2008.12.011","article-title":"Angiotensin II and the development of insulin resistance: implications for diabetes","volume":"302","author":"Olivares-Reyes","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"2022031210112042600_B34","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.2337\/db06-0391","article-title":"Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85\u03b1: the two sides of a coin","volume":"55","author":"Draznin","year":"2006","journal-title":"Diabetes"},{"key":"2022031210112042600_B35","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1161\/ATVBAHA.108.168021","article-title":"Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways","volume":"28","author":"Montezano","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210112042600_B36","doi-asserted-by":"crossref","first-page":"F1323","DOI":"10.1152\/ajprenal.90428.2008","article-title":"Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation","volume":"296","author":"Huang","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022031210112042600_B37","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1210\/en.2010-0350","article-title":"Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells","volume":"151","author":"Cascella","year":"2010","journal-title":"Endocrinology"},{"key":"2022031210112042600_B38","first-page":"963","article-title":"Mineralocorticoid receptor antagonists and endothelial function","volume":"9","author":"Maron","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"2022031210112042600_B39","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.2337\/db08-0961","article-title":"Increased MAPK activation and impaired insulin signaling in subcutaneous microvascular endothelial cells in type 2 diabetes: the role of endothelin-1","volume":"58","author":"Gogg","year":"2009","journal-title":"Diabetes"},{"key":"2022031210112042600_B40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/en.2010-0925","article-title":"11\u03b2-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-\/- mice","volume":"152","author":"Deuchar","year":"2011","journal-title":"Endocrinology"},{"key":"2022031210112042600_B41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.ATV.0000204635.75748.0f","article-title":"Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation","volume":"26","author":"Suzuki","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210112042600_B42","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/ATVBAHA.111.239558","article-title":"Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice","volume":"32","author":"Rask-Madsen","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210112042600_B43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/ATVBAHA.111.240358","article-title":"Accelerated atherosclerosis in Apoe-\/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1","volume":"32","author":"Galkina","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210112042600_B44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.ATV.0000254814.63768.3b","article-title":"Increased insulin-stimulated expression of arterial angiotensinogen and angiotensin type 1 receptor in patients with type 2 diabetes mellitus and atheroma","volume":"27","author":"Hodroj","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210112042600_B45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.yjmcc.2007.07.044","article-title":"Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis","volume":"43","author":"Ihara","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"2022031210112042600_B46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.lfs.2010.12.021","article-title":"The role of insulin growth factor on atherosclerosis and endothelial function: the effect on hyperlipidemia and aging","volume":"88","author":"Hirai","year":"2011","journal-title":"Life Sci"},{"key":"2022031210112042600_B47","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10930-010-9288-7","article-title":"Are elevated levels of IGF-1 caused by coronary arteriesoclerosis?: Molecular and clinical analysis","volume":"29","author":"Burchardt","year":"2010","journal-title":"Protein J"},{"key":"2022031210112042600_B48","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/ATVBAHA.110.210831","article-title":"Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-\/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability","volume":"30","author":"Shai","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210112042600_B49","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ajpath.2010.10.007","article-title":"IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype","volume":"178","author":"von der Th\u00fcsen","year":"2011","journal-title":"Am J Pathol"},{"key":"2022031210112042600_B50","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1210\/en.2009-0172","article-title":"Insulin and insulin-like growth factor-I receptors differentially mediate insulin-stimulated adhesion molecule production by endothelial cells","volume":"150","author":"Li","year":"2009","journal-title":"Endocrinology"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/62\/2\/313\/571514\/313.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/62\/2\/313\/571514\/313.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:32:48Z","timestamp":1667406768000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/62\/2\/313\/15462\/Mineralocorticoid-Receptor-Mediated-Vascular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,17]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,1,17]]},"published-print":{"date-parts":[[2013,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db12-0905","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,17]]}}}